Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Gene Activated Human Glucocerebrosidase----1件: 19
2Gene activated human glucocerebrosidase, velaglucerase alfa1件: Velaglucerase alfa1件: D09029 1件: GBA 💬4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬1件: 19
3Gene-Activated Human Glucocerebrosidase----1件: 19
4Gene-Activated Human Glucocerebrosidase 200U/vial----1件: 19
5Gene-Activated Human Glucocerebrosidase 400U/vial----1件: 19
6GLUCOCEREBROSIDASE----1件: 19
7GLUCOCEREBROSIDASE UMANO GENE-ATTIVATO----1件: 19
8Human Glucocerebrosidase (prGCD)1件: Taliglucerase alfa1件: D09675 1件: GBA 💬4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬1件: 19
9Plant cell expressed recombinant glucocerebrosidase (prGCD)1件: Taliglucerase alfa1件: D09675 1件: GBA 💬4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬1件: 19
10Plant Cell Recombinant Glucocerebrosidase----1件: 19
11Recombinant human derived macrophage-targeted beta-Glucocerebrosidase----1件: 19
12Recombinant human derived macrophage-targeted ß-Glucocerebrosidase----1件: 19
13Recombinant human glucocerebrosidase----1件: 19
14Recombinant Human Glucocerebrosidase (prGCD)1件: Taliglucerase alfa1件: D09675 1件: GBA 💬4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬1件: 19
15Taliglucerase alfa - Recombinant human glucocerebrosidase1件: Taliglucerase alfa1件: D09675 1件: GBA 💬4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬1件: 19